VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $4,960,112 | +94.1% | 159,952 | +68.4% | 0.51% | +71.7% |
Q3 2023 | $2,556,019 | -10.6% | 94,984 | +0.1% | 0.30% | -26.5% |
Q2 2023 | $2,858,312 | -11.9% | 94,929 | -5.3% | 0.40% | +9.5% |
Q1 2023 | $3,244,123 | +14.9% | 100,282 | +5.3% | 0.37% | +87.3% |
Q4 2022 | $2,822,262 | +14.5% | 95,218 | +35.2% | 0.20% | +15.2% |
Q1 2022 | $2,465,000 | +24.2% | 70,442 | +7.3% | 0.17% | +30.5% |
Q4 2021 | $1,985,000 | -0.1% | 65,648 | +3.6% | 0.13% | -0.8% |
Q3 2021 | $1,986,000 | +0.5% | 63,358 | +4.7% | 0.13% | -5.0% |
Q2 2021 | $1,976,000 | +23.4% | 60,501 | +33.5% | 0.14% | +12.1% |
Q1 2021 | $1,601,000 | +310.5% | 45,329 | +293.3% | 0.12% | +275.8% |
Q4 2020 | $390,000 | -8.0% | 11,525 | +1.9% | 0.03% | -19.5% |
Q3 2020 | $424,000 | -98.8% | 11,314 | +632.3% | 0.04% | -67.5% |
Q1 2017 | $36,258,000 | -7.8% | 1,545 | -8.1% | 0.13% | +869.2% |
Q3 2016 | $39,344,000 | +51.2% | 1,682 | -10.2% | 0.01% | +333.3% |
Q2 2016 | $26,028,000 | – | 1,873 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |